Literature DB >> 33619413

The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care.

E I Gusev1, M Yu Martynov1, A N Boyko1,2, I A Voznyuk3, N Yu Latsh1, S A Sivertseva4, N N Spirin5, N A Shamalov1,2.   

Abstract

The new coronavirus SARS-CoV-2 and the disease it causes COVID-19 involves not only respiratory system damage, but can also lead to disorders of the central and peripheral nervous system, as well as the muscular system. This article presents published data and our own observations on the course of neurological disorders in COVID-19 patients. There is a relationship between the severity of COVID-19 and the severity and frequency of neurological manifestations. Severe neurological disorders are mostly seen in severe cases of COVID-19 and include acute cerebrovascular accidents (aCVA), acute necrotizing encephalopathy, and Guillain-Barré syndrome. Factors potentially complicating the course of COVID-19 and increasing the development of neurological complications include arterial hypertension, diabetes mellitus, and chronic cardiac and respiratory system diseases. Questions of the possible effects of human coronaviruses on the course of chronic progressive neurological diseases are addressed using multiple sclerosis (MS) as an example. We discuss the management of patients with aCVA and MS depending on the risk of developing coronavirus infection. © Springer Science+Business Media, LLC, part of Springer Nature 2021.

Entities:  

Keywords:  COVID-19 SARS-CoV-2; Guillain–Barré syndrome; acute necrotizing encephalopathy; coronaviruses; multiple sclerosis; muscular system; nervous system; stroke

Year:  2021        PMID: 33619413      PMCID: PMC7889305          DOI: 10.1007/s11055-021-01050-0

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  40 in total

1.  Acute necrotizing encephalitis: a problem in diagnosis.

Authors:  J H Adams; W B Jennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-06       Impact factor: 10.154

2.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

Authors:  Shaobo Shi; Mu Qin; Bo Shen; Yuli Cai; Tao Liu; Fan Yang; Wei Gong; Xu Liu; Jinjun Liang; Qinyan Zhao; He Huang; Bo Yang; Congxin Huang
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

4.  Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.

Authors:  Patrick Gavin Kehoe; Steffenny Wong; Noura Al Mulhim; Laura Elyse Palmer; J Scott Miners
Journal:  Alzheimers Res Ther       Date:  2016-11-25       Impact factor: 6.982

5.  Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis.

Authors:  Jun Xu; Shuqing Zhong; Jinghua Liu; Li Li; Yong Li; Xinwei Wu; Zhijie Li; Peng Deng; Jingqiang Zhang; Nanshan Zhong; Yanqing Ding; Yong Jiang
Journal:  Clin Infect Dis       Date:  2005-09-12       Impact factor: 9.079

6.  Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis.

Authors:  P J Talbot; J S Paquette; C Ciurli; J P Antel; F Ouellet
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

Review 7.  The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Tsutomu Hashikawa
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

Review 8.  Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis.

Authors:  Marc Desforges; Alain Le Coupanec; Jenny K Stodola; Mathieu Meessen-Pinard; Pierre J Talbot
Journal:  Virus Res       Date:  2014-10-02       Impact factor: 3.303

9.  Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586

10.  Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients.

Authors:  Annie Boucher; Marc Desforges; Pierre Duquette; Pierre J Talbot
Journal:  Clin Immunol       Date:  2007-04-19       Impact factor: 3.969

View more
  1 in total

1.  The potential impact of Covid-19 on CNS and psychiatric sequels.

Authors:  Ali Dehghani; Elham Zokaei; Seyyed Mohammad Kahani; Elaheh Alavinejad; Mohammad Dehghani; Gholam Hossein Meftahi; Mohammad Reza Afarinesh
Journal:  Asian J Psychiatr       Date:  2022-04-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.